GENZYME CORP Income Tax Expense
GENZYME CORP reported Income Tax Expense of -$24.75 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2011-03-01
- GENZYME CORP income tax expense (benefit) for the quarter ending 2010-12-31 was $33.74M.
- GENZYME CORP income tax expense (benefit) for the quarter ending 2010-09-30 was $17.39M.
- GENZYME CORP income tax expense (benefit) for the quarter ending 2010-06-30 was -$19.95M, a 125.30% decline year-over-year.
- GENZYME CORP income tax expense (benefit) for the quarter ending 2010-03-31 was -$61.80M, a 178.34% decline year-over-year.
- GENZYME CORP income tax expense (benefit) for fiscal 2010 was -$24.75M, a 120.16% decline from fiscal 2009.
- GENZYME CORP income tax expense (benefit) for fiscal 2009 was $122.77M, a 40.85% decline from fiscal 2008.
- GENZYME CORP income tax expense (benefit) for fiscal 2008 was $207.56M.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 9 month as first filed | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2010-12-31 | $33.74M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $51.13M derived: sum of 2 quarters · filed 2011-03-01 | $31.18M derived: sum of 3 quarters · filed 2011-03-01 | -$24.75M 10-K · filed 2011-03-01 | |||
| 2010-09-30 | $17.39M 10-Q · filed 2010-11-09 | -$2.57M derived: sum of 2 quarters · filed 2010-11-09 | -$58.49M 10-Q · filed 2010-11-09 | -$101.91M derived: sum of 4 quarters · filed 2011-03-01 | |||
| 2010-06-30 | -$19.95M 10-Q/A · filed 2010-09-07 | -$81.75M 10-Q/A · filed 2010-09-07 | -$119.29M derived: sum of 3 quarters · filed 2011-03-01 | -$120.26M derived: sum of 4 quarters · filed 2011-03-01 | |||
| 2010-03-31 | -$61.80M 10-Q/A · filed 2010-05-11 | -$99.34M derived: sum of 2 quarters · filed 2011-03-01 | -$100.30M derived: sum of 3 quarters · filed 2011-03-01 | -$21.43M derived: sum of 4 quarters · filed 2011-03-01 | |||
| 2009-12-31 | -$37.54M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | -$38.50M derived: sum of 2 quarters · filed 2011-03-01 | $40.37M derived: sum of 3 quarters · filed 2011-03-01 | $122.77M 10-K · filed 2011-03-01 | $121.43M 10-K · filed 2010-03-01 | ||
| 2009-09-30 | -$965.00K 10-Q · filed 2010-11-09 | $522.00K 10-Q · filed 2009-11-02 | $77.91M derived: sum of 2 quarters · filed 2010-11-09 | $160.31M 10-Q · filed 2010-11-09 | $158.28M 10-Q · filed 2009-11-02 | $205.32M derived: sum of 4 quarters · filed 2011-03-01 | |
| 2009-06-30 | $78.87M 10-Q/A · filed 2010-09-07 | $157.75M 10-Q/A · filed 2010-09-07 | $206.28M derived: sum of 3 quarters · filed 2011-03-01 | $266.80M derived: sum of 4 quarters · filed 2011-03-01 | |||
| 2009-03-31 | $78.88M 10-Q/A · filed 2010-05-11 | $127.41M derived: sum of 2 quarters · filed 2011-03-01 | $187.93M derived: sum of 3 quarters · filed 2011-03-01 | $226.33M derived: sum of 4 quarters · filed 2011-03-01 | |||
| 2008-12-31 | $48.53M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $109.04M derived: sum of 2 quarters · filed 2011-03-01 | $147.45M derived: sum of 3 quarters · filed 2011-03-01 | $207.56M 10-K · filed 2011-03-01 | $204.46M 10-K · filed 2010-03-01 | ||
| 2008-09-30 | $60.51M 10-Q · filed 2009-11-02 | $98.92M derived: sum of 2 quarters · filed 2009-11-02 | $159.04M 10-Q · filed 2009-11-02 | ||||
| 2008-06-30 | $38.41M 10-Q/A · filed 2009-09-04 | $98.52M 10-Q/A · filed 2009-09-04 | |||||
| 2007-12-31 | $255.48M 8-K · filed 2010-06-14 |